EMJ GOLD: Pharma news, views and analysis
EMJ
Join the EMJ GOLD team for a weekly exploration of all things pharma, featuring thought-provoking conversations, insightful interviews with high-profile industry guests and discussions about the latest trends and innovations taking the pharmaceutical sphere by storm.
Whether its marketing, medical affairs, the use of digital techniques to create patient-centric approaches or something in between, there's something here for anyone interested in the pharmaceutical industry.
Whether its marketing, medical affairs, the use of digital techniques to create patient-centric approaches or something in between, there's something here for anyone interested in the pharmaceutical industry.
Episodes
Mentioned books
Sep 6, 2021 • 21min
Keren Leshem on Running a Women's Health Business
We talk to Keren Leshem, Chief Executive Officer, OCON Healthcare about how she transformed OCON's business strategy, the importance of educating women on their health and options, and how being mentored as well as acting as a mentor has shaped her career and outlook.
Aug 31, 2021 • 6min
Pharma's Month in Review
This week, we reflect on the highlights in pharma throughout August, covering the latest in COVID-19 therapy developments, the most notable mergers and acquisitions, marketing highlights, and the latest in research and development.
Aug 24, 2021 • 18min
Edmond Chan on Improving Patient Outcomes
This week, we talk to Edmond Chan, Senior Director, EMEA Therapeutic Area Lead, Haematology, Janssen, about the impact medical affairs can have on improving patient outcomes. He discusses the different approaches required to engage HCPs working in diabetes, immunology, and haematology, how to advance precision medicine, and steps that can be taken to improve the quality of life of those undergoing cancer treatment.
Aug 17, 2021 • 33min
Dr Jerome Kim on Vaccines
This week, we speak with Dr Jerome Kim, Director General, International Vaccine Institute, about vaccines. The conversation covers the nuances of the vaccine development process, the pharmaceutical industry's role in addressing vaccine hesitancy and refusal, and equitable distribution. He also shares his experience of working within the US military.
Aug 10, 2021 • 13min
Talking to Dirk Kosche
This week, we talk to Dirk Kosche, President, Established Markets, Astellas Pharma Europe Ltd, about turning innovation into value for patients, the role of the pharmaceutical industry in addressing health inequities, and his appreciation for the Japanese work culture.
Aug 3, 2021 • 5min
Pharma's Month in Review - August 2021
This week, we reflect on the highlights in pharma throughout July, covering the latest in COVID-19 developments, the most prestigious mergers and acquisitions, marketing standouts, and the latest in research and development.
Jul 27, 2021 • 45min
Talking to Jennifer Cain Birkmose
This week, we speak with Jennifer Cain Birkmose, Senior Pharmaceutical Leader in Market Access, Patient Access, and Patient Advocacy. She explores the idea of co-designing clinical trials and treatment with patients, discusses the concept behind reverse mentoring, and reveals how the rules of improvisation help her when leading teams.
Jul 20, 2021 • 26min
Talking to Vanessa Pott
This week, we talk to Vanessa Pott, Director, Global Patient Insights and Advocacy, Merck KGaA, about her path into patient advocacy, the importance of recognising and supporting informal and family carers, and an MS awareness campaign that saw Merck partner with the gaming platform, Twitch.
Jul 13, 2021 • 19min
Talking to Alexey Cherchago
This week, we speak with Alexey Cherchago, Head of Sales Excellence Europe, Sandoz, about leadership, how the role of the medical sales representative has evolved, and what the 'new normal' will look like within pharma's commercial teams.
Jul 6, 2021 • 5min
Pharma's Month in Review - July 2021
This week, we reflect on the highlights in pharma throughout June, covering the latest in COVID-19 therapy developments, the most notable mergers and acquisitions, marketing highlights, and the latest in research and development.
